Omalizumab: a New Treatment Option for Allergic Bronchopulmonary Aspergillosis (ABPA)
ABPA is an allergic infection of the airways. It is not yet clear why some people get ABPA while most of us do not as the infecting mould is inhaled by nearly all of us on a daily basis. For most of us this is not a problem as our lungs are lined with protective immune cells that destroy the mould before its can establish itself, but for those rare few with ABPA this did not happen and the
0 Response to "Omalizumab: a New Treatment Option for Allergic Bronchopulmonary Aspergillosis (ABPA)"
Post a Comment